Completed NA INTERVENTIONAL 2-arm NCT00491556

Preservation and Expansion of T-cell Subsets Following HAART De-intensification to Atazanavir/Ritonavir (ATV/r)

Preservation and Expansion of T-cell Subsets Following HAART De-intensification to Atazanavir/Ritonavir (ATV/r) in Adolescents With CD4 + T Cells > 350 Cells/mm3 Initiating HAART

Sponsor: International Maternal Pediatric Adolescent AIDS Clinical Trials Group

Conditions HIV Infections

Interventions Early Initiation of Highly Active Anti-Retroviral Therapy Standard Care

Updated 8 times since 2017 Last updated: Feb 27, 2017 Started: Oct 31, 2007 Primary completion: Jun 30, 2013 Completion: Jun 30, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates HIV Infections and is currently completed. International Maternal Pediatric Adolescent AIDS Clinical Trials Group leads this study, which shows 8 recorded versions since 2007 — indicating limited longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.

Status Flow

Change History

8 versions recorded

Sep 2025 — Present [monthly]

Completed NA
Sep 2024 — Sep 2025 [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA

▶ Show 3 earlier versions

May 2017 — Jun 2018 [monthly]

Completed NA
Feb 2017 — May 2017 [monthly]

Completed NA
Jan 2017 — Feb 2017 [monthly]

Completed NA

First recorded

Oct 2007

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

International Maternal Pediatric Adolescent AIDS Clinical Trials Group
National Institute of Mental Health (NIMH)
National Institute on Drug Abuse (NIDA)
University of North Carolina, Chapel Hill

Data source: University of North Carolina, Chapel Hill

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Aurora, United States , Baltimore, United States , Chicago, United States , Detroit, United States , Durham, United States , Fort Lauderdale, United States , Los Angeles, United States , Memphis, United States , Miami, United States , New Orleans, United States and 8 more locations